Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gilbert

Showing results (831-840 of 869) with videos related to

Pageof 87
Sort By:
Mbio|September 9, 2025
Bayesian estimation of HIV acquisition dates for prevention trialsRaabya Rossenkhan, Elena E Giorgi, Danica Shao, et al.
Nature Communications|September 11, 2024
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trialBo Zhang, Youyi Fong, Jonathan Fintzi, et al.
Plos Pathogens|June 29, 2023
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trialsNonhlanhla N Mkhize, Anna E J Yssel, Haajira Kaldine, et al.
Nature|September 11, 2012
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2Morgane Rolland, Paul T Edlefsen, Brendan B Larsen, et al.
Nature Medicine|August 22, 2022
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisitionPeter B Gilbert, Yunda Huang, Allan C deCamp, et al.
The New England Journal of Medicine|April 6, 2012
Immune-correlates analysis of an HIV-1 vaccine efficacy trialBarton F Haynes, Peter B Gilbert, M Juliana McElrath, et al.
Plos Pathogens|October 8, 2011
Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infectionsS Gnanakaran, Tanmoy Bhattacharya, Marcus Daniels, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2025
Analysis of antibody markers as immune correlates of risk of severe COVID-19 in the PREVENT-19 efficacy trial of the NVX-CoV2373 recombinant protein vaccineYouyi Fong, Yunda Huang, Ying Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2013
Genome of an arbuscular mycorrhizal fungus provides insight into the oldest plant symbiosisEmilie Tisserant, Mathilde Malbreil, Alan Kuo, et al.
Ebiomedicine|June 10, 2023
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisitionKelly E Seaton, Yunda Huang, Shelly Karuna, et al.
Pageof 87

Showing results (831-840 of 869) with videos related to

Sort By:
Pageof 87
Mbio|September 9, 2025
Bayesian estimation of HIV acquisition dates for prevention trialsRaabya Rossenkhan, Elena E Giorgi, Danica Shao, et al.
Nature Communications|September 11, 2024
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trialBo Zhang, Youyi Fong, Jonathan Fintzi, et al.
Plos Pathogens|June 29, 2023
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trialsNonhlanhla N Mkhize, Anna E J Yssel, Haajira Kaldine, et al.
Nature|September 11, 2012
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2Morgane Rolland, Paul T Edlefsen, Brendan B Larsen, et al.
Nature Medicine|August 22, 2022
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisitionPeter B Gilbert, Yunda Huang, Allan C deCamp, et al.
The New England Journal of Medicine|April 6, 2012
Immune-correlates analysis of an HIV-1 vaccine efficacy trialBarton F Haynes, Peter B Gilbert, M Juliana McElrath, et al.
Plos Pathogens|October 8, 2011
Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infectionsS Gnanakaran, Tanmoy Bhattacharya, Marcus Daniels, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2025
Analysis of antibody markers as immune correlates of risk of severe COVID-19 in the PREVENT-19 efficacy trial of the NVX-CoV2373 recombinant protein vaccineYouyi Fong, Yunda Huang, Ying Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2013
Genome of an arbuscular mycorrhizal fungus provides insight into the oldest plant symbiosisEmilie Tisserant, Mathilde Malbreil, Alan Kuo, et al.
Ebiomedicine|June 10, 2023
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisitionKelly E Seaton, Yunda Huang, Shelly Karuna, et al.
Pageof 87